Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
JPMorgan opened coverage of Benefit Systems with an Overweight rating and assigned a December 2027 price target of 6,685 Polish zloty, indicating roughly 25% upside from current levels. The $4.8 billion market-cap business, known for its MultiSport card and owned fitness clubs, is judged to benefit from low market penetration, consolidation opportu…
Myriad Genetics, a molecular diagnostic and precision medicine company, announced that its management will present at the 21st Annual Wells Fargo Healthcare Conference on September 10, 2026. The presentation will discuss the company’s portfolio and advancements in molecular testing and precision medicine.
Royal Philips and Imricor Medical Systems have launched a new Interventional MR (iMR) lab solution combining Philips' 1.5T MRI platform and Imricor's MR-compatible cardiac intervention systems. This solution aims to enable MRI-guided cardiac interventions with improved tissue visualization, reducing reliance on X-ray fluoroscopy and radiation expos…
AIM ImmunoTech presented at the Virtual Investor 'Why Now' on-demand conference, focusing on their lead product Ampligen's advancement in the Phase 2 DURIPANC trial for metastatic pancreatic cancer. The trial has successfully completed enrollment ahead of schedule, with the final patient dosed. Topline results from the primary endpoint evaluation a…
Outlook Therapeutics CEO Bob Jahr participated in the Virtual Investor "Why Now" on-demand conference highlighting the company's transition to a commercial-stage biopharmaceutical firm following the FDA approval of LYTENAVA, the only FDA-approved ophthalmic bevacizumab for wet AMD in the U.S. He emphasized the significant market opportunity, ongoin…
Akari Therapeutics presented at the Virtual Investor "Why Now" conference to showcase its novel antibody drug conjugates (ADCs) with PH1 RNA splicing modulator payloads targeting cancer. The company emphasizes the potential advantages of its lead candidate AKTX-101 and plans to initiate a First-In-Human trial by mid-2027, aiming to address limitati…
GRI Bio, a biotechnology company listed on NASDAQ, announced its feature in the 'Why Now' on-demand video webcast, showcasing its work on developing therapies for inflammatory, fibrotic, and autoimmune diseases.
Ernexa Therapeutics, a Nasdaq-listed biotechnology company, participated in a virtual investor conference to present its transition towards a clinical-stage company with its lead cell therapy candidate ERNA-101 advancing toward IND submission and an upcoming Phase 1 clinical trial. The company emphasized its innovative off-the-shelf iMSC platform t…
Moleculin Biotech's CEO Walter Klemp presented promising interim results from the pivotal Phase 2/3 MIRACLE trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML). The presentation emphasized the drug's differentiated clinical profile, ongoing enrollment, expanding commercial potential, and an upcoming interim analysis of 90 pat…
Arhaus celebrates its 40th anniversary by unveiling the Fall 2026 Collection, featuring a bold new color palette, expanded personalized stone program, and artisan-crafted wood furnishings. The collection emphasizes lasting design, sustainability, and personalized customer experiences across both residential and commercial sectors, reinforcing the b…
Kura Sushi USA, a technology-driven Japanese restaurant chain operating 95 locations in the U.S., announced participation in two investor conferences in September 2026. The company will host fireside chats at the Barclays Global Consumer Conference and the Piper Sandler Growth Frontiers Conference, aiming to enhance institutional investor engagemen…
CalciMedica Inc., a clinical-stage biopharmaceutical company focused on CRAC channel inhibition therapies, announced a 1-for-5 reverse stock split effective August 28, 2026. This move aims to bring its stock price in compliance with Nasdaq Capital Market's minimum bid price requirement. The reverse split will reduce the number of outstanding shares…
Verizon is leveraging its position as the Official 5G Network of the NFL to engage customers with free NFL tickets to every domestic game, exclusive VIP experiences with 22 NFL teams, and multiple football-themed rewards via its new Verizon Shine app. The campaign, starting August 31, offers thousands of free tickets, special offers, and premium NF…
Snail, Inc. (NASDAQ: SNAL) highlighted its expanding intellectual property portfolio and upcoming game releases at Gamescom 2026, showcasing internally developed AAA titles '9 Yin Sutra: Wuxia' and 'For The Stars', along with new content for established franchises like PixARK and ARK: Survival Ascended. The company's portfolio strategy focuses on I…
Ruanyun Edai Technology Inc. (NASDAQ: RYET) has signed a three-party memorandum of understanding with Intersect Holding and the Nanchang Institute of Science and Technology to develop a collaborative platform connecting vocational education, university research, technology commercialization, and institutional investment between Saudi Arabia and Chi…
Codexis, Inc., a leader in enzymatic solutions for complex therapeutics manufacturing, announced its participation in the Cantor Global Healthcare Conference 2026. Management will engage in a fireside chat discussing their proprietary enzyme technologies and manufacturing platforms for advanced therapeutics, including RNAi drugs.
CSX Corporation has announced the recipients of its 32nd annual Chemical Safety Excellence Awards, honoring 55 customers for exemplary safe transportation of hazardous materials on its rail network in 2025. Customers achieving milestone safety anniversaries were also recognized, underscoring the company's commitment to safety in hazardous material …
Kazia Therapeutics ($KZIA) is a small-cap biotech where upcoming clinical readouts and regulatory interactions could validate paxalisib as a best-in-class PI3K/mTOR inhibitor for brain and selected solid tumors. At a market cap of roughly $167M and a current price near $14.60, the stock is priced for outcome sensitivity. This trade targets asymmetr…
American Airlines Group Inc. will introduce seven international routes in 2027, with tickets on sale beginning Aug. 31. The carrier will use more of its newest long-range aircraft to launch daily summer service to multiple European cities from Philadelphia, New York and Charlotte, while also increasing frequencies on key Asia and transatlantic mark…
UBS has reiterated an Attractive rating on Chinese equities while reshuffling its Greater China focus list to favor companies it sees as beneficiaries of the country's AI build-out. The bank added five stocks at specified portfolio weights, highlighted growth drivers in transceivers and chip localization, removed several other names, and trimmed Te…
HealthEquity shares slipped 7.6% in pre-market trading after the company released its fiscal second-quarter 2027 results that aligned closely with Wall Street estimates. Revenue rose 8% year-over-year to $350.7 million and non-GAAP net income per diluted share reached $1.24, roughly in line with analyst expectations. The company reported record ope…
Alpha Modus Holdings, Inc. announced a strategic transaction to add approximately 3,170 Bitcoin (valued at over $200 million) to its balance sheet. This move is intended to materially increase shareholder equity and address the company’s outstanding Nasdaq shareholder equity deficiency. The company will continue its core AI and fintech operations, …
argenx has completed the acquisition of Forte Biosciences, adding the first-in-class anti-CD122 antibody, FB102, to its immunology pipeline. FB102 shows promise for treating autoimmune diseases such as vitiligo, celiac disease, and alopecia areata. The acquisition supports argenx's strategy to broaden its immunology portfolio and advance innovative…
Initial claims for state unemployment benefits fell by 4,000 to a seasonally adjusted 203,000 in the week ending August 22, signaling continued low levels of layoffs. At the same time, the U.S. goods trade deficit widened to $118.8 billion in July from $101.4 billion in June as exports fell and imports rose. These mixed signals leave labor-market r…
Salesforce climbed roughly 10.2% in pre-market trade to $226.67 after a sizeable fiscal Q2 2027 beat, but still trades at a forward P/E of 14.2x and a fair-value estimate of $310.79. The report featured a large EPS beat, raised guidance, outsized free cash flow and accelerating AI-related ARR, driving analysts to lift price targets. Technical indic…
